Parenteral Nutrition Filters Alert DSI/2026/011
Areazine synthesizes this MHRA medicine alert directly from MHRA's official public data feed. See our methodology for full source attribution and refresh cadence.
Administration of parenteral nutrition without a filter has been associated with adverse incidents including a fatal embolism.
What this MHRA medicine alert tells you, and what most readers miss
This notice was issued by MHRA on September 2, 2026 and geographically references United Kingdom. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - Medicine Alerts - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, mhra, medicine-alert.
What Happened
Administration of parenteral nutrition without a filter has been associated with a number of adverse incidents including an embolism which resulted in a fatal outcome.
Which Products Are Affected
The alert concerns the administration of Parenteral Nutrition for patients in all care settings. No specific product names, model numbers, or quantities are identified in the alert.
What You Should Do
Filters should be used during the administration of Parenteral Nutrition.
Why This Matters
The absence of filters during administration has been linked to serious adverse incidents, including one fatal outcome.
Source
MHRA - DSI/2026/011
Original source: MHRA Official Notice ↗
Related Medicine Alerts
All Medicine Alerts →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this MHRA medicine alert: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (840 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to September 2, 2026.
Frequently Asked Questions
Common questions about this MHRA medicine alert.